Did 26 NPS Detections Mean 26 Drug-Impaired Drivers in a California Crash Study?
Twenty-six drug detections are not the same as 26 people, and crash victims are not all drivers. Gerona and colleagues analyzed serum from 1,000 roadway crash victims in California. They confirmed eight different new psychoactive substances, or NPS, with 26 detections distributed across 17 cases.
Which denominator answers which question?
The 17 positive cases represent people with at least one confirmed NPS finding in the sampled cohort. The 26 detections count substance findings, so more than one detection can belong to the same case. Treating the detection count as a head count would overstate how many sampled people had an NPS result.
Among the 17 NPS-positive cases, seven were passengers and five were drivers. The others were three bicyclists, one pedestrian struck by a vehicle and one person using a mini-mobility device. Those roles matter: a result from an injured passenger cannot simply be relabeled as evidence that a driver was impaired.
What the laboratory established
The researchers used liquid chromatography with quadrupole time-of-flight mass spectrometry and confirmation and quantitation procedures. Bromazolam, para-fluorofentanyl and mitragynine were the most frequently detected NPS. Other recreational drugs were often co-detected.
A confirmed serum finding identifies a measured substance in the collected specimen. The number of co-detections does not independently quantify combined impairment, identify which drug contributed to a crash or establish that the tested person caused it.
Why this is not a statewide driver-risk estimate
The samples came from crash victims in Los Angeles and Sacramento over seven months, January through July 2024. The authors explain that the cohort did not include other at-risk people who were outside the qualifying emergency-department crash population. Geographic selection, eligibility rules and the collection period limit generalization.
This was not a comparison of all exposed drivers with a representative group of unexposed drivers to estimate their relative crash risk. The study provides valuable surveillance of drugs found in selected crash-victim specimens. Its case counts, substance counts and road-user roles should stay separate when the findings are described.
Source: Gerona R, Tomer D, Nielsen D, et al. New psychoactive substances in roadway crash victims in California. Frontiers in Toxicology. 2025;7:1572324. doi:10.3389/ftox.2025.1572324.



